← All stocks

Scilex Holding Co

SCLX Net selling

CIK 0001820190 #4816 in the set updated 21 Sep 2026

Bought (120 mo)

$356.33K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$12.77M

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$12.77M

4 of 4 sales

Net

−$12.42M

−$12.42M against sales at will

By person

10 insiders · 26 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Scilex Holding Co entity

10% owner

—

$12.77M (3)

−$12.77M

244,445,260

$131.85M

−7.8%

SHAH JAISIM

See Remarks

$197.17K (5)

—

+$197.17K

295,215

$159.24K

+1,759%

Ji Henry

Exec Chair, CEO and President

$62.05K (3)

—

+$62.05K

380,231

$205.10K

+25.6%

Chun Jay

Director

$56.39K (2)

—

+$56.39K

112,500

$60.68K

+150.0%

Wu Yue Alexander

Director

$18.99K (1)

—

+$18.99K

25,000

$13.49K

—

Ma Stephen Hoi

CFO, COO and Secretary

$18.94K (2)

—

+$18.94K

22,840

$12.32K

—

Lemus David

Director

$1.80K (1)

—

+$1.80K

2,000

$1.08K

—

Followwill Dorman

Director

$990.00 (1)

—

+$990.00

2,300

$1.24K

+666.7%

Sorrento Therapeutics, Inc. entity

10% owner

—

— (1)

$0.00

1,917,210

$1.03M

−98.6%

SCLX Stock Acquisition JV LLC entity

10% owner

—

958,263

$516.89K

−90.9%

No percentages here. This company's share count has moved by a factor of 35.0 over the window, from 6,955,697 to 243,312,885 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 64

Amendments (4/A) skipped 1

Filings about a different issuer 6

Unreadable filings 0

Joint filings 1

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 4

Transactions with no price 1

Shares from compensation/vesting 83,339,229

History held since 15 Nov 2022